Oramed Pharmaceuticals (FRA:OJU1) Short Interest


FRA:OJU1 Oramed Pharmaceuticals Inc FRA:OJU1
34 GF Score
Price €3.96
! 5 Warning Signs
View Full Analysis

What is Oramed Pharmaceuticals Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:OJU1 vs EQ, HUMA, NBP: Short Interest Comparison

For the Biotechnology subindustry, Oramed Pharmaceuticals's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Oramed Pharmaceuticals Short Interest vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Oramed Pharmaceuticals's Short Interest distribution charts can be found below:

* The bar in red indicates where Oramed Pharmaceuticals's Short Interest falls into.


FRA:OJU1
34GF Score
Oramed Pharmaceuticals Inc FRA:OJU1
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Oramed Pharmaceuticals Business Description

Address 1185 Avenue of the Americas, Third Floor, New York, NY, USA, 10036
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. The company has developed an oral dosage form intended to withstand the harsh environment of the gastrointestinal tract and effectively deliver active insulin or other proteins. Its product pipeline includes ORMD-0801 for Diabetes, ORMD-0801 for NASH, and ORMD 0901.
34GF Score

Get the complete analysis for FRA:OJU1

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.96
Price